Mayo Clinic's AI Vetting Sets New Trust Standard in Healthcare Tech

NEW YORK, NY – July 22, 2026 – In a move that signals a maturing market for artificial intelligence in healthcare, Rezonate, a company with deep roots in Asia's public health sector, announced today that its AI platform, kira™, has become a qualified solution on the prestigious Mayo Clinic Platform. The designation suggests a new era is dawning—one where AI tools are no longer just technologically promising but are rigorously vetted for safety, efficacy, and ethical integrity before they reach hospital workflows.

For years, hospital administrators and IT decision-makers have navigated a crowded and often confusing marketplace of AI solutions, each promising to revolutionize healthcare. The qualification of kira™, an omnichannel AI assistant designed to automate patient and staff communications, by a world-renowned institution like Mayo Clinic provides a powerful new filter for quality and trust.

A New Benchmark for Trust in Health AI

The term 'qualified solution' is far more than a simple partnership endorsement. It represents the culmination of a rigorous evaluation by the Mayo Clinic Platform Solutions Studio, a program designed to vet and prepare digital health technologies for real-world clinical and administrative environments. According to Mayo Clinic, this proprietary process scrutinizes solutions for their adherence to responsible AI principles, including fairness, algorithmic validity, and clinical safety.

"Mayo Clinic Platform is dedicated to advancing solutions that directly address the realities of healthcare delivery," said Steve Bethke, vice president of Solution Developer Market at Mayo Clinic Platform. "When a solution is on Mayo Clinic Platform and qualified, providers can trust it has been reviewed for adherence to responsible AI principles, all aimed at supporting care teams and improving patient outcomes."

This vetting process acts as a crucial de-risking mechanism for healthcare organizations. By providing what some industry insiders call a 'nutrition label' for AI, the program allows providers to adopt new technology with a higher degree of confidence, bypassing the lengthy and resource-intensive due diligence that often stalls innovation. For a sector grappling with issues of data security, algorithmic bias, and patient safety, this third-party validation from a trusted clinical entity is becoming the new gold standard.

Beyond the Chatbot: Redefining Healthcare Communication

At its core, Rezonate’s kira™ platform is engineered to tackle one of the most persistent and costly problems in healthcare: administrative gridlock. The platform is an omnichannel AI assistant and orchestration engine, meaning it can seamlessly engage with patients and staff across a wide array of channels, including chat, voice, SMS, WhatsApp, email, and even internal tools like Microsoft Teams.

It automates a host of high-volume, repetitive tasks that consume countless hours of staff time. These include appointment booking and rescheduling, pre-procedure counseling via voice, multilingual patient support, and post-discharge follow-ups. By handling these workflows, the platform aims to free up human staff to focus on more complex clinical and empathetic patient needs, a critical benefit amid widespread staff shortages and burnout.

The platform's reported metrics are substantial. Rezonate states that kira™ has already supported more than 83 million AI interactions globally, with over 12 million annual interactions in healthcare alone, across more than 60 languages. This scale, combined with a 94% client retention rate, points to a robust and effective system.

"Rezonate is proud to contribute kira, bringing omnichannel AI engagement capabilities that help providers improve access, streamline administrative workflows, and support patients throughout their care journey," stated Peiru Teo, CEO of Rezonate. "This work expands what healthcare organizations can achieve with AI, not as a standalone tool, but as an integrated solution that makes interactions more timely, personal, and effective."

Rezonate's Strategic Leap from Asia to America

While Rezonate may be a new name to some in the North American market, the company is a seasoned veteran. Operating for over a decade in Asia as KeyReply, it became a dominant force in the region's public sector, most notably being trusted by 100% of Singapore's public hospitals and accredited by the country's Ministry of Health. This extensive experience in a highly regulated and demanding healthcare environment has provided the company with a deep understanding of clinical governance and the nuances of patient engagement.

The rebranding to Rezonate and the strategic partnership with Mayo Clinic Platform mark a deliberate and significant expansion into the United States. Rather than entering the market as an unknown startup, the company is leveraging its proven track record and coupling it with one of the most credible validations available in American healthcare. This approach allows it to sidestep the 'credibility gap' that often plagues international firms entering the complex U.S. health tech landscape.

The qualification effectively serves as a powerful market entry tool, providing instant credibility and signaling to potential hospital clients that the kira™ platform has met an exceptionally high bar for performance and safety. This move positions Rezonate to compete not just as a technology vendor, but as a validated partner in healthcare transformation.

Navigating a Crowded Field with a Compass of Credibility

Rezonate enters a competitive arena filled with companies offering AI-driven patient engagement and administrative automation tools. However, the Mayo Clinic Platform qualification provides a key differentiator in a market where trust is paramount. While competitors may boast similar features, few can claim their solution has undergone such a thorough, clinically-led review for adherence to responsible AI principles.

This development highlights a broader trend: the shift from an open, often chaotic tech marketplace to curated ecosystems. As healthcare organizations become more sophisticated in their technology adoption, they are increasingly looking to trusted intermediaries to help them distinguish truly effective and safe solutions from the hype. Platforms like Mayo's are becoming essential for navigating the ethical complexities of AI, including mitigating bias, ensuring data privacy, and maintaining transparency.

The Rezonate announcement is more than a story about one company's success; it is a clear indicator of the direction of the entire health AI industry. As institutions continue to grapple with operational inefficiencies and the demand for better patient experiences, the role of rigorously vetted, responsibly designed AI is set to become not just an advantage, but a necessity.